Search results for Johnson
Johnson community
One keyword maps to one global community path.
People
Not Found
Tweets including Johnson
JOHNSON WILL NOT RUN FOR HOUSE GOP LEADER ROLE: CNN
*JOHNSON WILL NOT RUN FOR HOUSE GOP LEADER ROLE: CNN
*JOHNSON WILL NOT RUN FOR HOUSE GOP LEADER ROLE: CNN
Johnson & Johnson reports 94% success rate in trial of coronary artery device $JNJ #stocks# #business# #markets#
Johnson Controls ($JCI) is cashing in on the data center boom, with backlog surging 43% to a record $23B.
Americas orders jumped 58%, while the company raised expectations for continued double-digit organic growth in 2027.
Show more
Johnson Controls Q4 2026 Earnings
- Adjusted EPS: $1.66 (est $1.59)
- Net Sales: $7.1B (est $7.04B)
- Organic Sales: +12% (est +9.39%)
- Sees Q1 Adjusted EPS: $1.15 To $1.20 (est $1.13)
JOHNSON & JOHNSON ANNOUNCES ERLEADA® (APALUTAMIDE) TREATMENT BEFORE AND AFTER SURGERY REDUCES RISK OF RECURRENCE OR DEATH BY 62% VERSUS SURGERY ALONE IN HIGH-RISK PROSTATE CANCER
JOHNSON & JOHNSON ANNOUNCES NEW DATA SHOWING TREMFYA® (GUSELKUMAB) IS THE ONLY IL-23 TO DELIVER DURABLE FISTULA REMISSION THROUGH 48 WEEKS IN CROHN'S DISEASE WITH PERIANAL FISTULA
Johnson & Johnson Q3 26 Earnings:
- Adj EPS: $2.59 (est $2.52)
- Sales: $25.40B (est $25.4B)
- Medicine Rev: $16.76B (est $16.59B)
- Darzalex Rev: $4.24B (est $4.31B)
- Tremfya Rev: $2.40B (est $2.21B)
- MedTech Sales: $8.64B (est $8.77B)
- Sees FY Sales: $101B To $101.4B (est $100.8B To $101.4B)
- Sees FY Adj EPS: $11.05 To $11.15 (est $10.96 To $11.11)
- Sees FY Adj Oper EPS: $10.95 To $11.05 (est $10.86 To $11.01)
- CFO Says Leaning Toward Orthopaedic Unit Spinoff Instead Of Sale
Show more
Johnson & Johnson Q3 26 Earnings:
- Adj EPS: $2.59 (est $2.52)
- Sales: $25.40B (est $25.4B)
- Medicine Rev: $16.76B (est $16.59B)
- Darzalex Rev: $4.24B (est $4.31B)
- Tremfya Rev: $2.40B (est $2.21B)
- MedTech Sales: $8.64B (est $8.77B)
- Sees FY Sales: $101B To $101.4B (est $100.8B To $101.4B)
- Sees FY Adj EPS: $11.05 To $11.15 (est $10.96 To $11.11)
- Sees FY Adj Oper EPS: $10.95 To $11.05 (est $10.86 To $11.01)
- CFO Says Leaning Toward Orthopaedic Unit Spinoff Instead Of Sale
Show more